Recommendation from Iron & Steel and Pharmaceuticals & Drugs Sector

Recommendation from Iron & Steel and Pharmaceuticals & Drugs Sector

The scrips in this column have been recommended with a 15-day investment horizon in mind and carry high risk. Therefore, investors are advised to take into account their risk appetite before investing, as fundamentals may or may not back the recommendations.

 

Rate this article:
4.0

2 comments on article "Recommendation from Iron & Steel and Pharmaceuticals & Drugs Sector"

Avatar image

Diwakar Kumar

I recently subscribed to dsij magazine still it is asking for subscription purchase. Very much disappointing.


Avatar image

Dinesh Ladha

when the issues of DSIJ publish in a month I could not find dates.

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary30-Apr, 2025

Multibaggers1-May, 2025

Mindshare30-Apr, 2025

Multibaggers30-Apr, 2025

Mindshare30-Apr, 2025

Knowledge

MF30-Apr, 2025

Knowledge29-Apr, 2025

MF22-Apr, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR